Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03204422
Other study ID # 17JL85
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2017
Est. completion date December 31, 2021

Study information

Verified date February 2022
Source Beijing Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The accurate evaluation of daily salt or sodium intake is difficult to implement in clinical practice and large epidemiological studies. 24-h urinary sodium excretion (USE) is considered the gold standard, but is expensive and has a high participant burden. To further explore the association between 24-h USE and spot urines in Chinese population, it was proposed that using collected multiple spot urine samples could be estimated for 24-h USE in Chinese children and adults.


Description:

Specific Aims 1. To collect multiple spot urine samples and a 24-h urine sample in a population of Chinese Children and adults. All participants will collect a spot urine in separate jugs during the 24-h period, recording every urination time. 2. Validate previous finding that 24-h USE is estimated inaccurately by using only the second morning void. 3. Explore a statistical formula to estimate 24-h USE by multi-time spot urine. The study plan to enroll 200 children and 100 adults to collect a whole 24-h urine spot by spot continuously. After a laboratory examination of sodium concentration from both spot urine samples and 24-h urine sample, the exploratory estimation using multi-spot urine to assess 24-h urinary sodium excretion will analyzed statistically. The validation for the estimation method will be conducted in Chinese population as well. Urine sodium and potassium concentration in each urine specimen will be determined by ion selective electrode methods and creatinine using enzymatic methods.The model established by using linear model step by step. And the validation analysis conducted through correlation analysis, bias distribution, residual analysis and Bland-Altman plot to assess accuracy. All statistics analysis will be conducted using Statistical Analysis System software version 9.4.


Recruitment information / eligibility

Status Completed
Enrollment 330
Est. completion date December 31, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 60 Years
Eligibility Inclusion Criteria: - Aged 5-60 years - Provide written informed consent - Without any renal diseases or conditions which could affect renal function Exclusion Criteria: - Pregnant - Taking diuretic medicine or pharmaceutical using patients, e.g. some hypertension or heart diseases patients - Cancer patients or some other severe patient

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
no any other intervention

Locations

Country Name City State
China Beijing Children's Hospital Beijing

Sponsors (2)

Lead Sponsor Collaborator
Beijing Children's Hospital Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary urinary sodium excretion concentration the concentration measured by laboratory examination for the 24 hour urine sample and spot urine samples day 1
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03465657 - Sodium Sources and Sodium Intake in a Representative Sample of Spanish Children N/A